Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 11, Number 1—January 2005


Multidrug-Resistant Acinetobacter baumannii

Aharon Abbo*, Shiri Navon-Venezia*, Orly Hammer-Muntz*, Tami Krichali*, Yardena Siegman-Igra*, and Yehuda Carmeli*Comments to Author 
Author affiliations: *Tel Aviv Sourasky Medical Center, Tel Aviv, Israel

Main Article

Table 3

Multivariate analysis for risk factors for Acinetobacter baumannii*†

Parameter‡ OR 95% CI p value
Male sex 3.84 1.63–8.99 0.002
Ischemic heart disease 3.35 1.44–7.77 0.005
Mechanical ventilation 6.27 2.27–17.33 <0.001
Penicillin use§ 0.38 0.16–0.90 0.029
Metronidazole use 2.33 0.98–5.83 0.071
Any home antimicrobial drug treatment 4.74 1.31–17.15 0.018

*OR, odds ratio; CI, confidence interval.
†Adjusted for length of hospital stay prior to entry to the study.
‡All parameters had been present before A. baumannii identification.
§Including semisynthetics with or without a β-lactamase inhibitor (never sulbactam).

Main Article

Top of Page The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO